Daily Dose: Fatigue More Common in Chronic vs Episodic Migraine
Your daily dose of the clinical news you may have missed.
Oral vs Transdermal Hormone Therapy after Menopause Linked to Increased Risk of NAFLD
Among postmenopausal women taking hormones orally, the NAFLD prevalence increased from 25.3 to 29.4% while it decreased from 24 to 17.3% in those using the transdermal route.
Children with Disabilities Can Grow, Thrive, and Be Part of their Communities: Expert Perspective
Renowned pediatric rehabilitation physician Amy Houtrow, MD, PhD, MPH, highlights the scope of the specialty and its core objectives.
Pegozafermin Receives Breakthrough Therapy Designation for Nonalcoholic Steatohepatitis
The US Food and Drug Administration granted BTD to pegozafermin for the treatment of patients with NASH.
Daily Dose: Dupilumab Potent Against Uncontrolled COPD with Type 2 Inflammation
GLP-1 Mimetics, SGLT-2 Inhibitors Understudied in Black Populations in Pivotal Trials, Benefits Questioned
Pivotal cardiovascular outcome trials that evaluated cardiorenal benefits of the newer classes were not designed to consider racial/ethnic variations, researchers state.
Physiatry to Primary Care: Think Outside the Box—Call Us
How can a nearby physiatrist help your patient with hypertension? If comorbid arthritis has the person couchbound, a consult and some PT could go a long way.
ACIP Recommends Maternal RSV Vaccine to Protect Newborns
Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.
Daily Dose: Early Childhood Obesity Treatment Found Effective Long-Term
Biosimilar Liraglutide Noninferior to Reference Product in Persons with Type 2 Diabetes: Phase 3 Trial
The biosimilar to the GLP-1 mimetic Victoza proved noninferior for reduction of HbA1c and had similar positive effects on body weight, lipids, and blood pressure.
That Patient with Neck Pain in Exam Rm 2 May not Need a Neurology Referral Today
The patient with neck pain might be better off referred to a physiatrist for additional evaluation and possibly treatment, according to PM&R physician Atul Patel, MD.
Empagliflozin Wins FDA Approval for the Treatment of Adults with CKD
Empagliflozin is approved to lower the risk of sustained decline in eGFR, end-stage kidney disease, CV death, and hospitalization in adults with CKD at risk of progression.
Daily Dose: Antihypertensive Treatment Throughout Late Life Lowers Risk of Dementia
Waist-to-Hip Ratio More Consistently Associated with Mortality vs BMI: New Research
Waist-to-hip ratio was more powerfully and consistently associated with risk of all-cause mortality than BMI or FMI, but can it replace BMI as a clinical indicator?
Abbott, WeightWatchers Announce App Integrating FreeStyle Libre 2 CGM Data
The new app is designed to help persons with diabetes understand how food and activity impact blood glucose levels and to revise behavior accordingly.
Mental Health in the US: Happiest States in 2023
What state has highest share of adult depression? Or the lowest divorce rate? Find the answers and more insights from a nationwide analysis, here.
Daily Dose: Risky Alcohol Use Among US Adults Prescribed Alcohol-Interactive Medications
Long-COVID Rehabilitation Interventions Improve Symptoms but Research on Safety Still Needed
Meta-analysis: Among persons with symptoms of long COVID, respiratory and exercise training were effective but pooled information on safety was "uncertain, imprecise."
A PM&R Generalist May be Just What Primary Care Needs: New Interview
A member of the board of the American Academy of Physical Medicine & Rehabilitation highlights the breadth of his practice.
For Episodic Migraine, Both OTC and New Oral Prescription Medications Provide Meaningful Pain Relief
In episodic migraine, both traditional oral OTC medications and newly approved classes led to significantly better improvements in pain compared with placebo.
